Recommendation ID
NG191/13
Question

What are the views, preferences and experiences of people with COVID-19-associated pulmonary aspergillosis (CAPA), and their families or carers, on:
• available tests for diagnosing CAPA
• available treatments for CAPA?

Any explanatory notes
(if applicable)

P: people who have been diagnosed with and treated for CAPA, and their families or carers. Subgroups of particular interest include young people and children, and pregnant women.

I: tests for diagnosing CAPA and treatments for CAPA.

C: people who have been diagnosed with, and had treatment for, CAPA in hospital.


Source guidance details

Comes from guidance
COVID-19 rapid guideline: managing COVID-19
Number
NG191
Date issued
March 2021

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 17/12/2021